Table 3 Summary of drug administration and dose adjustments

From: Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours

DHA–paclitaxel dose level (mg m−2)

Number of patients

660

3

880 → 660

9

880

3

Total

15

DHA–paclitaxel dose level (mg m−2)

Number of courses given at dose level

660

26

880

28

Total

54

  1. Note: → indicates DHA–paclitaxel dose reduction.